Here, we identified a novel small molecule, SE486-11, from a random drug library screen which enhanced the cytopathic effects of SAHA across a panel of neuroblastoma cell lines and completely blocked tumour growth in MYCN transgenic mice and zebrafish. The gene discussed is MYCN; the disease is neuroblastoma.